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Hemostasis and thrombosis hinge on the formation of
thrombin. The underlying reaction mechanism is a web of
proenzyme–enzyme conversions, controlled by positive and
negative feedback reactions [1]. Current paradigm has it that
thrombin formation is the results of chemical interactions
between the components of this web and therefore is uniquely
determined by the initial concentrations and reaction constants
of its components [2,3].
Essential steps of the thrombin forming process occur at
membranes that contain negatively charged phospholipids [1].
In an in vitro model system such procoagulant phospholipids
are normally added in the form of relatively small vesicles that
remain in suspension, so that the binding sites for the clotting
factors are available in free solution. In vivo the binding takes
place on membrane surfaces that present in a wound or
ruptured plaque [4]. Factor VII(a) binds to tissue factor
incorporated in cell membranes and factors II, X(a), V(a),
IX(a) and VII(a) on adhering and aggregating activated
platelets and on membrane remnants. Experiments in the
presence of platelets and tissue factor bearing cells suggest that,
as soon as such structures are present, physical transport
through diffusion might play a role in determining thrombin
generation velocities [5,6,7]. In coagulation experiments in
plasma in vitro, procoagulant phospholipids are added to
platelet-poor plasma (PPP) in the form of vesicles; in platelet-
rich plasma (PRP), they are provided by activated platelets [8].
At the moment that a clot forms, 98% of thrombin is still
to be generated [9,10]. The total amount of thrombin formed is
an important determinant of the quality of hemostasis or the
extent of thrombosis [11] and this thrombin is almost all
formed within the fibrin mesh of the clot. In that mesh, the
plasma is stagnant and the procoagulant surfaces of blood
platelets and membrane fragments stick to the fibrin fibers [12].
Prothrombin conversion and other activation reactions thus
are likely to be located on the insoluble fibrin mesh rather than
in free and homogeneous solution and it is conceivable that not
only chemical reaction rates but also diffusional transport to
these surfaces determines the rate of thrombin formation.
Whether diffusion or chemical interaction is rate limiting can
be decided on the basis of temperature dependence. Diffusion
velocity is proportional to absolute temperature, i.e. it will show
a 14% increase between 10 and 50 C, whereas biochemical
reactions will roughly double their pace if the temperature is
raisedby10 C (see e.g. 13).Here,we showthat the temperature
dependency of thrombin generation in clotting plasma is such
that we must assume that, when a clot has formed, diffusion
starts to co-determine the rate of thrombin formation.
Thrombin inactivation, on the contrary, is caused by
stoichiometric reaction with specific plasma proteins, the most
important of which is antithrombin. In contrast to the
activation reactions, inactivation takes place in free solution
and therefore is likely to be less diffusion dependent.
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If the velocities of both activation and inactivation are
determined by chemical reaction rates, a rise in temperature
will enhance both reactions to roughly the same extent and the
change in thrombin activity with temperature will be small. If
diffusional transport would govern activation but thrombin
inactivation would be a chemical reaction, then activation
would increase 3% by raising the temperature from 25 to
35 C, but inactivation would double so that an almost 50%
decrease of the free thrombin formed would result. If diffusion
plays a role that is more important in the activation reaction
than in the inactivation, a limited decrease of thrombin activity
would be seen with rising temperatures.
We tested thrombin generation in plasma at four temper-
atures: 25, 30, 35 and 40 C under three conditions. A: in
defibrinated plasma with added procoagulant phospholipids;
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B: in normal plasma with the same amount of added
phospholipids and C: in PRP (Fig. 1 from left to right).
Defibrination with Arvin is known to precipitate fibrin but not
otherwise to affect the clotting system [14].
To 80 lL of citrated plasma, we added 20 lL of amixture of
30 pM recombinant tissue factor and 24 lM phospholipid
vesicles (20% of dioleoyl phosphatidyl serine, 20% of dioleoyl
phosphatidyl ethanolamine and 52% of dioleoyl phosphatidyl
choline and 8% of cholesterol). Thrombin generation was
started by adding 20lL of CaCl2 containing 2.5 mM of the
thrombin substrate Z-Gly-Gly-Arg-aminomethylcoumarine
(AMC). The fluorescent product AMC was detected by its
emission at 460 nM upon excitation at 390 nM [15]. When
fibrinogen is present, the clot forms at the moment that also the
fluorogenic thrombin substrate starts to be converted, the bulk
of thrombin being formed within the clot.
In Fig. 1, it is seen that, with increasing temperature, the lag-
time of thrombin formation shortens under all circumstances.
This is to be expected because during the lag-time all reactions
take place in free solution and will follow chemical rate laws,
they i.e. are accelerated significantly by a rise in temperature.
In Fig. 1, middle and right frames, it is seen that as soon as
fibrin is present less thrombin is formed at higher temperatures
than at lower ones. This indicates that thrombin forming
reactions are less accelerated by a rise in temperature than
thrombin inactivating reactions are, which can be explained by
assuming that the role of diffusion in the generation of
thrombin is more important than in its decay.
This effect of diffusion starts to play a rate determining role in
the generation of thrombin around the moment of clot
formation. So, whereas the initiation phase is a purely chemical
process, the contribution of physical restraints to thrombin
generation during the propagation phase is not to be neglected.
In mixtures without fibrinogen or in mathematical simulation,
thrombin generation velocity is governed by chemical conver-
sion ratesonlyanddiffusion isnot taken intoaccount. Inmodels
where the prothrombin converting enzyme is adsorbed at a
macroscopic surface, thrombingeneration is diffusion limited at
all but extreme concentrations of the reactants [16]. Because of
the transitionof chemical to diffusional limited reaction velocity
around themoment of clotting, neither of these approaches can
be quantitatively extrapolated to the in vivo situation. It follows
that thrombin generation in the body is best modeled by
measuring it directly in a sample of isolated organ i.e. in clotting
PRPwith addition of the relevant components of the vessel wall
(tissue factor, thrombomodulin) and/or white cells.
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Fig. 1. Fluorescence development from a thrombin-specific substrate in plasma. Left frame: defibrinated PPP with added phospholipids; middle frame:
non-defibrinated PPPwith added phospholipids; right frame: PRP. In all experiments, the fluorescence wasmeasured in 120 lLof citrated plasma to which
(final concentrations) 5 pM TF, 16.7 mM of CaCl2 and 0.42 mM of ZGGR-AMC were added at zero-time. In each frame, from left to right the
temperatures were: 40, 35, 30 and 25 C.
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